Hostname: page-component-6766d58669-vgfm9 Total loading time: 0 Render date: 2026-05-22T02:32:53.042Z Has data issue: false hasContentIssue false

Posterior Reversible Encephalopathy Syndrome Due to Chronic Obstructive Pulmonary Disease

Published online by Cambridge University Press:  16 March 2020

Himanshu Gupta
Affiliation:
McMaster University, Medicine - Neurology, Hamilton, Ontario, Canada
Anas Alrohimi
Affiliation:
University of Alberta, Medicine – Neurology, Edmonton, Canada King Saud University, Medicine – Neurology, Riyadh, Saudi Arabia
Nabeela Nathoo
Affiliation:
University of Alberta, Medicine – Neurology, Edmonton, Canada
Tomasz Nowacki
Affiliation:
University of Alberta, Medicine – Neurology, Edmonton, Canada
Zaeem A. Siddiqi*
Affiliation:
University of Alberta, Medicine – Neurology, Edmonton, Canada
*
Correspondence to: Dr. Zaeem A. Siddiqi, MD, PhD, Professor, Division of Neurology, Faculty of Medicine & Dentistry, University of Alberta, 7-112 Clinical Sciences Building, 11350 83 Avenue, Edmonton, ABT6G 2G3, Canada. Email: zsiddiqi@ualberta.ca
Rights & Permissions [Opens in a new window]

Abstract

Information

Type
Letter to the Editor
Copyright
Copyright © 2020 The Canadian Journal of Neurological Sciences Inc.
Figure 0

Figure 1: Constellation of findings most supportive of posterior reversible encephalopathy syndrome (PRES). Magnetic resonance imaging (MRI) of the brain revealed multifocal, predominantly subcortical increased T2 signal primarily involving the frontal and parietal lobes (A), superior aspect of the thalami bilaterally and right occipital lobe (B and C), and cerebellar hemispheres (D) with no diffusion restriction (E and F).

Figure 1

Table 1: Cases of COPD and hypercarbia manifesting as PRES